Global Plant-based Soft Capsules (Softgel) 麻豆原创 Growth 2024-2030

Publication ID:

LPI07243415

Publication Date:

July 16, 2024

Pages:

122

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Retailing [2]

Consumer & Retail [3]

Description:

The global Plant-based Soft Capsules (Softgel) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淧lant-based Soft Capsules (Softgel) Industry Forecast鈥� looks at past sales and reviews total world Plant-based Soft Capsules (Softgel) sales in 2023, providing a comprehensive analysis by region and market sector of projected Plant-based Soft Capsules (Softgel) sales for 2024 through 2030. With Plant-based Soft Capsules (Softgel) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plant-based Soft Capsules (Softgel) industry.
This Insight Report provides a comprehensive analysis of the global Plant-based Soft Capsules (Softgel) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plant-based Soft Capsules (Softgel) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Plant-based Soft Capsules (Softgel) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plant-based Soft Capsules (Softgel) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plant-based Soft Capsules (Softgel).
United States market for Plant-based Soft Capsules (Softgel) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Plant-based Soft Capsules (Softgel) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Plant-based Soft Capsules (Softgel) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Plant-based Soft Capsules (Softgel) players cover Catalent, Procaps Laboratorios, Eurocaps, Sirio Pharma (Best Formulations), Aenova, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Plant-based Soft Capsules (Softgel) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Carrageenan
Starch
Gellan Gum
Segmentation by Application:
Rx and OTC
Supplements
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Catalent
Procaps Laboratorios
Eurocaps
Sirio Pharma (Best Formulations)
Aenova
Captek
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
Baihe Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Plant-based Soft Capsules (Softgel) market?
What factors are driving Plant-based Soft Capsules (Softgel) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plant-based Soft Capsules (Softgel) market opportunities vary by end market size?
How does Plant-based Soft Capsules (Softgel) break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Plant-based Soft Capsules (Softgel) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Plant-based Soft Capsules (Softgel) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Plant-based Soft Capsules (Softgel) by Country/Region, 2019, 2023 & 2030
2.2 Plant-based Soft Capsules (Softgel) Segment by Type
2.2.1 Carrageenan
2.2.2 Starch
2.2.3 Gellan Gum
2.3 Plant-based Soft Capsules (Softgel) Sales by Type
2.3.1 Global Plant-based Soft Capsules (Softgel) Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Plant-based Soft Capsules (Softgel) Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Plant-based Soft Capsules (Softgel) Sale Price by Type (2019-2024)
2.4 Plant-based Soft Capsules (Softgel) Segment by Application
2.4.1 Rx and OTC
2.4.2 Supplements
2.4.3 Other
2.5 Plant-based Soft Capsules (Softgel) Sales by Application
2.5.1 Global Plant-based Soft Capsules (Softgel) Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Plant-based Soft Capsules (Softgel) Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Plant-based Soft Capsules (Softgel) Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Plant-based Soft Capsules (Softgel) Breakdown Data by Company
3.1.1 Global Plant-based Soft Capsules (Softgel) Annual Sales by Company (2019-2024)
3.1.2 Global Plant-based Soft Capsules (Softgel) Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Plant-based Soft Capsules (Softgel) Annual Revenue by Company (2019-2024)
3.2.1 Global Plant-based Soft Capsules (Softgel) Revenue by Company (2019-2024)
3.2.2 Global Plant-based Soft Capsules (Softgel) Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Plant-based Soft Capsules (Softgel) Sale Price by Company
3.4 Key Manufacturers Plant-based Soft Capsules (Softgel) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plant-based Soft Capsules (Softgel) Product Location Distribution
3.4.2 Players Plant-based Soft Capsules (Softgel) Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Plant-based Soft Capsules (Softgel) by Geographic Region
4.1 World Historic Plant-based Soft Capsules (Softgel) 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Plant-based Soft Capsules (Softgel) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Plant-based Soft Capsules (Softgel) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Plant-based Soft Capsules (Softgel) 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Plant-based Soft Capsules (Softgel) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Plant-based Soft Capsules (Softgel) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Plant-based Soft Capsules (Softgel) Sales Growth
4.4 APAC Plant-based Soft Capsules (Softgel) Sales Growth
4.5 Europe Plant-based Soft Capsules (Softgel) Sales Growth
4.6 Middle East & Africa Plant-based Soft Capsules (Softgel) Sales Growth
5 Americas
5.1 Americas Plant-based Soft Capsules (Softgel) Sales by Country
5.1.1 Americas Plant-based Soft Capsules (Softgel) Sales by Country (2019-2024)
5.1.2 Americas Plant-based Soft Capsules (Softgel) Revenue by Country (2019-2024)
5.2 Americas Plant-based Soft Capsules (Softgel) Sales by Type (2019-2024)
5.3 Americas Plant-based Soft Capsules (Softgel) Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plant-based Soft Capsules (Softgel) Sales by Region
6.1.1 APAC Plant-based Soft Capsules (Softgel) Sales by Region (2019-2024)
6.1.2 APAC Plant-based Soft Capsules (Softgel) Revenue by Region (2019-2024)
6.2 APAC Plant-based Soft Capsules (Softgel) Sales by Type (2019-2024)
6.3 APAC Plant-based Soft Capsules (Softgel) Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Plant-based Soft Capsules (Softgel) by Country
7.1.1 Europe Plant-based Soft Capsules (Softgel) Sales by Country (2019-2024)
7.1.2 Europe Plant-based Soft Capsules (Softgel) Revenue by Country (2019-2024)
7.2 Europe Plant-based Soft Capsules (Softgel) Sales by Type (2019-2024)
7.3 Europe Plant-based Soft Capsules (Softgel) Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Plant-based Soft Capsules (Softgel) by Country
8.1.1 Middle East & Africa Plant-based Soft Capsules (Softgel) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Plant-based Soft Capsules (Softgel) Revenue by Country (2019-2024)
8.2 Middle East & Africa Plant-based Soft Capsules (Softgel) Sales by Type (2019-2024)
8.3 Middle East & Africa Plant-based Soft Capsules (Softgel) Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plant-based Soft Capsules (Softgel)
10.3 Manufacturing Process Analysis of Plant-based Soft Capsules (Softgel)
10.4 Industry Chain Structure of Plant-based Soft Capsules (Softgel)
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plant-based Soft Capsules (Softgel) Distributors
11.3 Plant-based Soft Capsules (Softgel) Customer
12 World Forecast Review for Plant-based Soft Capsules (Softgel) by Geographic Region
12.1 Global Plant-based Soft Capsules (Softgel) 麻豆原创 Size Forecast by Region
12.1.1 Global Plant-based Soft Capsules (Softgel) Forecast by Region (2025-2030)
12.1.2 Global Plant-based Soft Capsules (Softgel) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Plant-based Soft Capsules (Softgel) Forecast by Type (2025-2030)
12.7 Global Plant-based Soft Capsules (Softgel) Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Catalent
13.1.1 Catalent Company Information
13.1.2 Catalent Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.1.3 Catalent Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Catalent Main Business Overview
13.1.5 Catalent Latest Developments
13.2 Procaps Laboratorios
13.2.1 Procaps Laboratorios Company Information
13.2.2 Procaps Laboratorios Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.2.3 Procaps Laboratorios Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Procaps Laboratorios Main Business Overview
13.2.5 Procaps Laboratorios Latest Developments
13.3 Eurocaps
13.3.1 Eurocaps Company Information
13.3.2 Eurocaps Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.3.3 Eurocaps Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Eurocaps Main Business Overview
13.3.5 Eurocaps Latest Developments
13.4 Sirio Pharma (Best Formulations)
13.4.1 Sirio Pharma (Best Formulations) Company Information
13.4.2 Sirio Pharma (Best Formulations) Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.4.3 Sirio Pharma (Best Formulations) Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sirio Pharma (Best Formulations) Main Business Overview
13.4.5 Sirio Pharma (Best Formulations) Latest Developments
13.5 Aenova
13.5.1 Aenova Company Information
13.5.2 Aenova Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.5.3 Aenova Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Aenova Main Business Overview
13.5.5 Aenova Latest Developments
13.6 Captek
13.6.1 Captek Company Information
13.6.2 Captek Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.6.3 Captek Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Captek Main Business Overview
13.6.5 Captek Latest Developments
13.7 Bahrain Pharma
13.7.1 Bahrain Pharma Company Information
13.7.2 Bahrain Pharma Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.7.3 Bahrain Pharma Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bahrain Pharma Main Business Overview
13.7.5 Bahrain Pharma Latest Developments
13.8 Robinson Pharma
13.8.1 Robinson Pharma Company Information
13.8.2 Robinson Pharma Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.8.3 Robinson Pharma Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Robinson Pharma Main Business Overview
13.8.5 Robinson Pharma Latest Developments
13.9 Aland
13.9.1 Aland Company Information
13.9.2 Aland Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.9.3 Aland Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Aland Main Business Overview
13.9.5 Aland Latest Developments
13.10 Fuji Capsule
13.10.1 Fuji Capsule Company Information
13.10.2 Fuji Capsule Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.10.3 Fuji Capsule Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Fuji Capsule Main Business Overview
13.10.5 Fuji Capsule Latest Developments
13.11 Sunsho Pharmaceutical
13.11.1 Sunsho Pharmaceutical Company Information
13.11.2 Sunsho Pharmaceutical Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.11.3 Sunsho Pharmaceutical Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Sunsho Pharmaceutical Main Business Overview
13.11.5 Sunsho Pharmaceutical Latest Developments
13.12 Erkang
13.12.1 Erkang Company Information
13.12.2 Erkang Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.12.3 Erkang Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Erkang Main Business Overview
13.12.5 Erkang Latest Developments
13.13 Baihe Group
13.13.1 Baihe Group Company Information
13.13.2 Baihe Group Plant-based Soft Capsules (Softgel) Product Portfolios and Specifications
13.13.3 Baihe Group Plant-based Soft Capsules (Softgel) Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Baihe Group Main Business Overview
13.13.5 Baihe Group Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.